Woodford Investment Management

Neil Woodford's Patient Capital trust has raised £800m during its offer period, a record for a London-listed investment trust.

Woodford Investment Management, Ruffer, Sarasin and Invesco are among the groups backing a new share placing by Oakley Capital's private equity trust.

Neil Woodford has introduced a currency hedge on his Woodford Equity Income fund for the first time in the belief the European Central Bank's QE programme may prompt further euro weakness.

As Woodford Investment Management gears up for the launch of its Patient Capital investment trust, Investment Week visited the company's Oxford offices to quiz senior personnel about their plans for the future.

Woodford Investment Management (WIM) is to take a 15% performance fee of any excess returns above the 10% annual return target on its Patient Capital investment trust.

News of Neil Woodford's forthcoming trust investing in early stage companies has prompted comparisons with venture capital trusts (VCTs), but analysts say they are unlikely to appeal to the same kinds of investors.

Investment Quorum has unveiled a series of funds it is backing to navigate currency wars and unpredictable central bank action in 2015, said the group's CIO Peter Lowman.

Woodford Investment Management (WIM) is seeking to raise an initial £200m for the launch of the Woodford Patient Capital investment trust, a portfolio of 50-100 quoted and unquoted businesses.

The changing face of investment over 20 years

Lower oil prices have been hailed as a welcome boost to the global economy, but could they also be a harbinger of declining demand in the global economy? Woodford IM's Stephen Lamacraft explains.